Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2014			2013		2012
Net sales				(restated)		(restated)
Interventional Cardiology	$	2,092		$	1,995	$	2,116
Peripheral Interventions	861			805		764
Cardiovascular	2,953			2,800		2,880
Cardiac Rhythm Management	1,922			1,882		1,887
Electrophysiology	228			154		145
Rhythm Management	2,150			2,036		2,032
Endoscopy	1,343			1,277		1,190
Urology and Women's Health	542			505		489
Neuromodulation	474			454		367
MedSurg	2,359			2,236		2,046
Net sales allocated to reportable segments	7,462			7,072		6,958
Sales generated from business divestitures	4			58		122
Impact of foreign currency fluctuations	(86		)	13		169
	$	7,380		$	7,143	$	7,249

Reconciliation of depreciation by reportable segment to total [Table Text Block]

	Year Ended December 31,
(in millions)	2014		2013			2012
Depreciation expense			(restated)			(restated)
Cardiovascular	$	120	$	111		$	107
Rhythm Management	92		99			109
MedSurg	75		73			75
Depreciation expense allocated to reportable segments	287		283			291
Impact of foreign currency fluctuations	—		(4		)	(3		)
	$	287	$	279		$	288

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2014			2013			2012
Income (loss) before income taxes				(restated)			(restated)
Cardiovascular	$	767		$	665		$	685
Rhythm Management	289			211			217
MedSurg	746			679			590
Operating income allocated to reportable segments	1,802			1,555			1,492
Corporate expenses and currency exchange	(308		)	(203		)	(132		)
Goodwill and intangible asset impairment charges and acquisition-, divestiture-, litigation-, and restructuring-related net charges	(1,357		)	(822		)	(4,833		)
Amortization expense	(438		)	(410		)	(395		)
Operating income (loss)	(301		)	120			(3,868		)
Other expense, net	(208		)	(343		)	(239		)
	$	(509	)	$	(223	)	$	(4,107	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	As of December 31,
(in millions)	2014		2013
Total assets
Cardiovascular	$	1,501	$	1,545
Rhythm Management	1,329		1,343
MedSurg	982		1,026
Total assets allocated to reportable segments	3,812		3,914
Goodwill	5,898		5,693
Other intangible assets, net	5,606		5,950
All other corporate assets	1,726		1,014
	$	17,042	$	16,571

Reconciliation of sales by division and region to consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2014		2013		2012
Net sales			(restated)*		(restated)*
Interventional Cardiology	$	2,057	$	1,997	$	2,179
Cardiac Rhythm Management	1,912		1,886		1,908
Endoscopy	1,323		1,280		1,239
Peripheral Interventions	850		809		787
Urology and Women’s Health	535		505		500
Neuromodulation	472		453		367
Electrophysiology	227		155		147
	7,376		7,085		7,127
Sales generated from divested businesses	4		58		122
	$	7,380	$	7,143	$	7,249
United States	$	3,885	$	3,743	$	3,756
Japan	678		744		931
Other countries	2,813		2,598		2,440
	7,376		7,085		7,127
Sales generated from divested businesses	4		58		122
	$	7,380	$	7,143	$	7,249

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	As of December 31,
(in millions)	2014		2013		2012
Long-lived assets
United States	$	1,002	$	998	$	1,065
Ireland	197		240		252
Other foreign countries	308		308		247
Property, plant and equipment, net	1,507		1,546		1,564
Goodwill	5,898		5,693		5,973
Other intangible assets, net	5,606		5,950		6,289
	$	13,011	$	13,189	$	13,826